Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)
Clinical trial NCT00144170 · COMPLETED
Trial details
- NCT number
- NCT00144170
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2008-10-01
- Enrollment
- 882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.